More recently, Friedrich and colleagues have shown that R-2-hydroxyglutarate in IDH1-mutant gliomas could induce infiltrating macrophages toward an immunosuppressive state [29], as investigated in a GL261 glioma model overexpressing mutant IDH [29]. Here, IDH1 is linked to central nervous system cancer.